...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

Yes, a poor cash period.

They need to preserve whatever cash they have as I see it.

 

Koo

Share
New Message
Please login to post a reply